U.S. Markets close in 2 hrs 27 mins

The Performance of Johnson & Johnson’s Cardiovascular Segment

Daniel Collins
The Performance of Johnson & Johnson’s Cardiovascular Segment

Johnson & Johnson’s (JNJ) Cardiovascular segment generated revenues of $1.52 billion in the first quarter of 2018 compared to $1.48 billion in the first quarter of 2017, which reflected ~2.8% YoY growth.